JPS5976021A - Ｆｋ−５６５物質含有リポソ−ム製剤 - Google Patents

Ｆｋ−５６５物質含有リポソ−ム製剤

Info

Publication number
JPS5976021A
JPS5976021A JP57186642A JP18664282A JPS5976021A JP S5976021 A JPS5976021 A JP S5976021A JP 57186642 A JP57186642 A JP 57186642A JP 18664282 A JP18664282 A JP 18664282A JP S5976021 A JPS5976021 A JP S5976021A
Authority
JP
Japan
Prior art keywords
substance
liposome
buffered saline
phosphate buffered
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP57186642A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0314292B2 (enExample
Inventor
Toru Kino
亨 木野
Kunio Nakahara
中原　邦夫
Hatsuo Aoki
青木　初男
Tomoaki Iwasa
岩佐　知明
Yuji Tokunaga
徳永　雄二
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to JP57186642A priority Critical patent/JPS5976021A/ja
Publication of JPS5976021A publication Critical patent/JPS5976021A/ja
Publication of JPH0314292B2 publication Critical patent/JPH0314292B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP57186642A 1982-10-22 1982-10-22 Ｆｋ−５６５物質含有リポソ−ム製剤 Granted JPS5976021A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP57186642A JPS5976021A (ja) 1982-10-22 1982-10-22 Ｆｋ−５６５物質含有リポソ−ム製剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57186642A JPS5976021A (ja) 1982-10-22 1982-10-22 Ｆｋ−５６５物質含有リポソ−ム製剤

Publications (2)

Publication Number Publication Date
JPS5976021A true JPS5976021A (ja) 1984-04-28
JPH0314292B2 JPH0314292B2 (enExample) 1991-02-26

Family

ID=16192155

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57186642A Granted JPS5976021A (ja) 1982-10-22 1982-10-22 Ｆｋ−５６５物質含有リポソ−ム製剤

Country Status (1)

Country Link
JP (1) JPS5976021A (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6230708A (ja) * 1985-04-11 1987-02-09 Takeda Chem Ind Ltd リポソ−ム製剤の製造法
US4666889A (en) * 1983-11-10 1987-05-19 Fujisawa Pharmaceutical Co., Ltd. Method for combatting viral infections
WO1994011017A1 (fr) * 1992-11-16 1994-05-26 Fujisawa Pharmaceutical Co., Ltd. Preparation buvable
JPH0818973B2 (ja) * 1984-08-08 1996-02-28 ザ リポソ−ム，カムパニ−，インコ−ポレ−テツド 脱水リポソ−ム

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666889A (en) * 1983-11-10 1987-05-19 Fujisawa Pharmaceutical Co., Ltd. Method for combatting viral infections
JPH0818973B2 (ja) * 1984-08-08 1996-02-28 ザ リポソ−ム，カムパニ−，インコ−ポレ−テツド 脱水リポソ−ム
JPS6230708A (ja) * 1985-04-11 1987-02-09 Takeda Chem Ind Ltd リポソ−ム製剤の製造法
WO1994011017A1 (fr) * 1992-11-16 1994-05-26 Fujisawa Pharmaceutical Co., Ltd. Preparation buvable

Also Published As

Publication number Publication date
JPH0314292B2 (enExample) 1991-02-26

Similar Documents

Publication Publication Date Title
US4241046A (en) Method of encapsulating biologically active materials in lipid vesicles
US4235871A (en) Method of encapsulating biologically active materials in lipid vesicles
JP3007627B2 (ja) 天然化学物質六酸化四砒素の新規の抗腫瘍治療剤としての用途及びその薬学的組成物
EP0374181A1 (en) Method of manufacturing unilamellar lipid vesicles
IE62548B1 (en) Liposomes with positive excess charge
ES2303114T3 (es) Metodo para cargar medicamentos en liposomas.
JPS62294432A (ja) リン脂質を基材としたリポソ−ムと医薬組成物
JPS5976021A (ja) Ｆｋ−５６５物質含有リポソ−ム製剤
CN114099692B (zh) 一种抗菌肽-细胞膜复合物、制备方法和应用
Marrs et al. Acute toxicity of T2 mycotoxin to the guinea-pig by inhalation and subcutaneous routes
WO1980001456A1 (en) Pharmaceutical composition and process for the preparation thereof
JPH01197431A (ja) 感染症治療剤
JP3085963B2 (ja) 人工血液
Owen et al. A phase I clinical evaluation of liposome-entrapped doxorubicin (Lip-Dox) in patients with primary and metastatic hepatic malignancy
CN119157837B (zh) 藿香黄酮醇纳米脂质体的制备及吸入治疗急性肺损伤的应用
CN102973508A (zh) 一种复方黄芪多糖脂质体长效注射液及其制备方法
Zamecnik et al. Protection of Animals Against CI. welchii (Type A) Toxin by Injection of Certain Purified Lipids.
JPH02188532A (ja) リポソームワクチン
CN107669497A (zh) 一种柔性脂质体的制备方法
CN115054700B (zh) 一种共载盐酸伊立替康和卡培他滨的靶向脂质体及其制备方法和应用
Bader et al. Action of polymyxin B on bacterial membranes, I. Binding to the O-antigenic lipopolysaccharide of Salmonella Typhimurium
Rosenberg et al. The Lung Surfactant and Immune System Response to Intratracheal Administration of “Empty” Liposomes
ODDIS et al. Wegener's granulomatosis with delayed pulmonary and colonic involvement
Darke et al. Fulminating staphylococcal pneumonia associated with influenza virus C
JPH03173814A (ja) リポソーム製剤